Envista Holdings Corporation is a global manufacturer and distributor of dental products, technologies, and services. Operating in over 120 countries, the company provides dental professionals with implants, orthodontics, imaging systems, and infection prevention products. It was formed as a spin-off from Danaher Corporation to consolidate multiple legacy dental brands under a single platform.
Financial Statements
In thousands, USD
FY 2025
FY 2024
FY 2023
FY 2022
Total Revenues
2,719,500
2,510,600
2,566,500
2,569,100
Cost of Sales
1,232,800
1,137,900
1,126,000
1,094,300
Gross Profit
1,486,700
1,372,700
1,440,500
1,474,800
Selling, General & Administrative Expenses
1,156,600
1,158,000
1,056,900
1,055,500
Research & Development Expenses
114,000
99,100
93,800
100,100
Other Operating Expenses
—
1,153,800
258,300
—
Operating Profit
216,100
(1,038,200)
31,500
319,200
Interest Expense
(36,600)
(46,400)
(63,400)
(38,400)
Non-Operating Income
—
—
—
3,100
Total Non-Operating Income
(36,600)
(46,400)
(63,400)
(35,300)
Income Before Provision for Income Taxes
177,200
(1,084,700)
(54,900)
283,900
Provision for Income Taxes
130,200
33,900
45,300
45,900
Consolidated Net Income
47,000
(1,118,600)
(100,200)
238,000
Net Income Attributable to Discontinued Operations
—
—
—
5,100
Net Income Attributable to Common Shareholders
47,000
(1,118,600)
(100,200)
243,100
Basic EPS
0.28
-6.50
-0.60
1.49
Diluted EPS
0.28
-6.50
-0.60
1.37
Basic Weighted Average Shares Outstanding
168,000
172,200
166,900
162,900
Diluted Weighted Average Shares Outstanding
169,200
172,200
166,900
177,600
Shares Outstanding
163,800
172,200
171,500
163,200
FY 2025
FY 2024
FY 2023
FY 2022
Cash and Cash Equivalents
1,211,700
1,069,100
940,000
606,900
Total Cash and Cash Equivalents
1,211,700
1,069,100
940,000
606,900
Accounts Receivable
—
—
407,500
393,500
Total Trade Receivables
—
—
407,500
393,500
Inventories
288,100
241,000
258,800
300,800
Other Current Assets
—
—
137,400
123,400
Total Current Assets
1,499,800
1,310,100
1,743,700
1,424,600
Net Property, Plant & Equipment
142,100
142,800
434,700
425,400
Net Intangible Assets
—
—
954,000
1,086,700
Goodwill
—
—
3,292,200
3,496,600
Other Long-Term Assets
—
—
180,500
153,700
Total Assets
5,679,000
5,350,500
6,605,100
6,587,000
Accounts Payable
—
—
179,500
228,300
Accrued Expenses
—
—
455,700
471,400
Short-Term Debt
—
116,000
115,300
510,000
Current Portion of Leases
39,000
34,500
30,300
27,000
Total Current Liabilities
39,000
150,500
780,800
1,236,700
Long-Term Debt
1,448,300
1,278,300
1,398,100
870,700
Leases
110,400
118,900
109,900
121,400
Other Long-Term Liabilities
—
—
142,400
151,300
Total Long-Term Liabilities
1,558,700
1,397,200
1,650,400
1,143,400
Total Liabilities
1,597,700
1,547,700
2,431,200
2,380,100
Common Stock
1,800
1,700
1,700
1,600
Treasury Stock
(224,500)
(50,500)
—
—
Additional Paid-in Capital
3,882,600
3,842,100
3,758,200
3,699,000
Accumulated Other Comprehensive Income
(113,200)
(371,100)
(217,200)
(225,100)
Retained Earnings
(440,400)
(487,400)
631,200
731,400
Total Common Shareholders' Equity
3,106,300
2,934,800
4,173,900
4,206,900
Total Shareholders' Equity
3,106,300
2,934,800
4,173,900
4,206,900
Total Liabilities and Shareholders' Equity
5,679,000
5,350,500
6,605,100
6,587,000
FY 2025
FY 2024
FY 2023
FY 2022
Net Income
47,000
(1,118,600)
(100,200)
243,100
Depreciation & Amortization
116,000
123,100
135,600
137,800
Share-Based Compensation Expense
37,600
35,300
30,700
30,500
Other Adjustments
66,200
1,199,300
281,000
14,000
Changes in Trade Receivables
(48,500)
10,000
(17,000)
(71,000)
Changes in Inventories
(29,100)
3,600
35,100
(39,900)
Changes in Accounts Payable
7,500
(1,200)
(46,300)
44,500
Changes in Accrued Expenses
116,000
134,500
(12,000)
(133,000)
Changes in Other Operating Activities
(37,000)
(49,500)
(31,200)
(43,300)
Cash from Operating Activities
275,700
336,500
275,700
182,700
Capital Expenditure
(45,300)
(33,800)
(58,200)
(75,700)
Proceeds from Sale of Property, Plant & Equipment
500
100
6,100
3,300
Purchases of Investments
(9,900)
(32,800)
—
—
Proceeds from Sale of Investments
10,400
9,700
10,700
—
Payments for Business Acquisitions
—
—
—
(696,200)
Proceeds from Business Divestments
—
—
—
73,900
Other Investing Activities
(6,800)
2,200
(21,000)
37,400
Cash from Investing Activities
(51,100)
(54,600)
(62,400)
(657,300)
Issuance of Short-Term Debt
115,400
—
—
124,000
Repayments of Short-Term Debt
—
—
—
(124,000)
Net Issuance / (Repayments) of Short-Term Debt
115,400
—
—
0
Issuance of Long-Term Debt
—
—
823,700
300
Repayments of Long-Term Debt
(116,300)
(100,000)
(690,000)
(500)
Net Issuance / (Repayments) of Long-Term Debt
(116,300)
(100,000)
133,700
(200)
Issuance of Common Shares
2,800
2,400
11,300
21,800
Repurchases of Common Shares
(172,800)
(5,300)
(7,900)
(9,100)
Net Issuance / (Repurchases) of Common Shares
(170,000)
(2,900)
3,400
12,700
Other Financing Activities
(800)
—
(18,200)
—
Cash from Financing Activities
(170,900)
(103,700)
118,900
12,500
Effect of Exchange Rate Changes on Cash and Cash Equivalents
88,900
(49,100)
900
(4,600)
Increase / (Decrease) in Cash, Cash Equivalents and Restricted Cash